GL1X · GenesisL1 explorer

MolNFT v1 · #98245 · protein

Crystal structure of the receptor-binding domain from newly emerged middle east respiratory syndrome coronavirus

4L3N · S protein: “Crystal structure of the receptor-binding domain from newly emerged middle east respiratory syndrome…”. X-ray diffraction, 1 ligand (NAG), 4 pockets (best druggability 0.63). MolNFT v1 #98245 on GenesisL1: 3D structure…

PDB
4L3N
Type
protein
Length
419 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
S protein
UniProt
M4SVE7
Ligands
NAG
Pockets
4 · best druggability 0.63

Structure

x-ray diffraction · 2 distinct chains · 18% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AS proteinprotein20917% helix, 36% strandM4SVE7
BS proteinprotein21018% helix, 36% strandM4SVE7

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 8 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12970.630.8038EDO
21390.460.7722empty
3890.400.7718empty
4510.250.7314empty

Interfaces

1 interface between chains.

  • A–B · 328 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide, 4 glycan (disulfide, N-glycosylation).

Compared structures

  • 4L3N · Crystal structure of the receptor-binding domain from newly emerged Middle East… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.